Senate Democrats say they plan to challenge a congressional ruling that strikes down a proposal sponsored by Sen. Raphael Warnock (D-Ga.) to cap insulin prices from the Inflation Reduction Act, according to a Democrat who he knows the plan.
So far, Warnock’s proposal to cap out-of-pocket insulin costs at $35 per month is in the bill, but lawmakers are expected to rule on the Senate floor that it does not meet the Byrd rule, which prohibits on policy making in the budget. reconciliation bills that have a knock-on effect on spending and revenue.
But the Democrats plan to challenge the parliament’s control on the floor, which means they would need 60 votes to waive an objection to the provision of insulin in the bill.
Any attempt to overturn the congressman is unlikely to get 10 Republican votes, but it will put Republicans on record as opposing a $35 monthly cap on patient insulin costs, which Democrats can use as political ammo in the elections. mid term.
“I think it’s hard for elected officials to go home, as everyone has said now, and try to explain, if they choose to vote that way, why they’re not supporting relief for the millions of Americans who are crushed by these insulin bills. ,” Senate Finance Committee Chairman Ron Wyden (D-Ore.) said before the breakdown on the floor.
Maine Senator Susan Collins (R) said it was “unfortunate” that Democrats were turning the issue into a political football.
Collins has sponsored a bipartisan bill with Sen. Jeanne Shaheen (DN.H.) to lower insulin costs.
Their bill would encourage insulin manufacturers to reduce their list prices and limit out-of-pocket costs for patients with diabetes by ensuring that group and individual health plans waive deductibles and cost-sharing up to a maximum of $35 a month, according to a summary. available at their offices.
“I think it’s unfortunate that it was included” in the reconciliation package, Collins said of the insulin proposal that is expected to be defeated on the floor Saturday.
Added by Mychael Schnell.